{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:47:58Z","timestamp":1791510478681,"version":"4.3.4"},"reference-count":59,"publisher":"American Association for Cancer Research (AACR)","issue":"10","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Anchorage-independent triple-negative breast cancer (TNBC) cells exhibit elevated levels of the tryptophan (TRP)-catabolizing enzyme tryptophan 2,3-dioxygenase 2 (TDO2) compared with the same cells grown under two-dimensional culture conditions. Tracing of 13C11-TRP demonstrated that anchorage-independent culture and\/or inflammatory cytokines that activate NF-\u03baB increase TRP catabolism and production of downstream catabolites such as kynurenine, which activate the aryl hydrocarbon receptor (AhR). TDO2 expression is heterogeneous within TNBC cell lines. To determine the function of TDO2, both pharmacologic inhibition and genetic manipulation were conducted. TDO2 knockdown revealed a compensatory increase in indoleamine 2,3-dioxygenase 1 (IDO1), a nonhomologous TRP-catabolizing enzyme, indicating that dual inhibition of these two enzymes is necessary to reliably block TRP catabolism. Thus, we tested a newly developed TDO2\/IDO1 dual inhibitor, AT-0174, and found that it effectively inhibits TNBC TRP catabolism. Furthermore, AT-0174 treatment or AhR inhibitor significantly decreased TNBC anchorage-independent survival, invasive capacity, and expression of mesenchymal genes and proteins, whereas exogenous kynurenine increased invasion through AhR-mediated zinc finger E-box\u2013binding homeobox 1 (ZEB1) expression. Thus, dual inhibition of TDO2\/IDO1 may prove efficacious against TNBC progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>TDO2 is more highly expressed than the nonhomologous TRP-catabolizing enzyme IDO1 in TNBC. We find that TDO2 knockdown can lead to a compensatory increase in IDO1. Therefore, we tested a newly developed TDO2\/IDO1 dual inhibitor and found that it decreases TRP catabolism, anchorage-independent survival, and invasive capacity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0272","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T10:01:36Z","timestamp":1727085696000},"page":"2699-2713","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-8740","authenticated-orcid":false,"given":"Li-Wei","family":"Kuo","sequence":"first","affiliation":[{"name":"Cancer Biology Training Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 1"},{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2790-7780","authenticated-orcid":false,"given":"Lyndsey S.","family":"Crump","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-2863","authenticated-orcid":false,"given":"Kathleen","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-9147","authenticated-orcid":false,"given":"Michelle M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-8191","authenticated-orcid":false,"given":"Jessica L.","family":"Christenson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3981-5960","authenticated-orcid":false,"given":"Nicole S.","family":"Spoelstra","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-6752","authenticated-orcid":false,"given":"Micaela Kalani","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1674-0997","authenticated-orcid":false,"given":"Amy","family":"Argabright","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7296-4963","authenticated-orcid":false,"given":"Julie A.","family":"Reisz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2258-6490","authenticated-orcid":false,"given":"Angelo","family":"D\u2019Alessandro","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4700-4140","authenticated-orcid":false,"given":"Meher P.","family":"Boorgula","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 4"},{"name":"Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7055-7128","authenticated-orcid":false,"given":"Andrew","family":"Goodspeed","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 4"},{"name":"Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1415-4200","authenticated-orcid":false,"given":"Mike","family":"Bickerdike","sequence":"additional","affiliation":[{"name":"Antido Therapeutics, Melbourne, Australia. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5809-5271","authenticated-orcid":false,"given":"Benjamin G.","family":"Bitler","sequence":"additional","affiliation":[{"name":"Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9960-0991","authenticated-orcid":false,"given":"Jennifer K.","family":"Richer","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"2026031614542029600_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2026031614542029600_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026031614542029600_bib3","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"2026031614542029600_bib4","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.3346\/jkms.2024.39.e156","article-title":"Anchorage dependence and cancer metastasis","volume":"39","author":"Lee","year":"2024","journal-title":"J Korean Med Sci"},{"key":"2026031614542029600_bib5","doi-asserted-by":"crossref","first-page":"e49987","DOI":"10.1371\/journal.pone.0049987","article-title":"miR-200c targets a NF-\u03baB up-regulated TrkB\/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer","volume":"7","author":"Howe","year":"2012","journal-title":"PLoS One"},{"key":"2026031614542029600_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2026031614542029600_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-030-73856-3_9","article-title":"The TGF\u03b2 and androgen receptor signaling pathways converge to support anoikis resistance in triple negative breast cancer","volume-title":"Anoikis: how the extracellular matrix regulates life-or-death decisions","author":"Rosas","year":"2021"},{"key":"2026031614542029600_bib8","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/0008-5472.CAN-15-2011","article-title":"A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer","volume":"75","author":"D\u2019Amato","year":"2015","journal-title":"Cancer Res"},{"key":"2026031614542029600_bib9","doi-asserted-by":"crossref","first-page":"562823","DOI":"10.3389\/fonc.2020.562823","article-title":"TDO2 promotes the EMT of hepatocellular carcinoma through kyn-AhR pathway","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"2026031614542029600_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.omto.2020.03.013","article-title":"Comprehensive analysis of the expression and prognosis for TDO2 in breast cancer","volume":"17","author":"Liu","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"2026031614542029600_bib11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/s12935-021-02228-9","article-title":"Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway","volume":"21","author":"Wu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"2026031614542029600_bib12","first-page":"1","article-title":"Tryptophan catabolism in epithelial ovarian carcinoma","volume":"14","author":"Smith","year":"2019","journal-title":"Trends Cancer Res"},{"key":"2026031614542029600_bib13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2767-9764.CRC-23-0513","article-title":"Targeting tryptophan catabolism in ovarian cancer to attenuate macrophage infiltration and PD-L1 expression","volume":"4","author":"Crump","year":"2024","journal-title":"Cancer Res Commun"},{"key":"2026031614542029600_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br J Cancer"},{"key":"2026031614542029600_bib15","doi-asserted-by":"crossref","first-page":"e19823","DOI":"10.1371\/journal.pone.0019823","article-title":"The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells","volume":"6","author":"Opitz","year":"2011","journal-title":"PLoS One"},{"key":"2026031614542029600_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1158\/1541-7786.MCR-18-0362","article-title":"A role for tryptophan-2,3-dioxygenase in CD8 T-cell suppression and evidence of tryptophan catabolism in breast cancer patient plasma","volume":"17","author":"Greene","year":"2019","journal-title":"Mol Cancer Res"},{"key":"2026031614542029600_bib17","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.7150\/jca.31727","article-title":"Role of IDO and TDO in cancers and related diseases and the therapeutic implications","volume":"10","author":"Ye","year":"2019","journal-title":"J Cancer"},{"key":"2026031614542029600_bib18","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/s41591-021-01544-x","article-title":"A phase 1\/2 trial of an immune-modulatory vaccine against IDO\/PD-L1 in combination with nivolumab in metastatic melanoma","volume":"27","author":"Kjeldsen","year":"2021","journal-title":"Nat Med"},{"key":"2026031614542029600_bib19","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3389\/fimmu.2019.01801","article-title":"Limitations and off-target effects of tryptophan-related IDO inhibitors in cancer treatment","volume":"10","author":"G\u00fcnther","year":"2019","journal-title":"Front Immunol"},{"key":"2026031614542029600_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/13543776.2019.1556638","article-title":"Current state on tryptophan 2,3-dioxygenase inhibitors: a patent review","volume":"29","author":"Kozlova","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"2026031614542029600_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejmech.2018.11.010","article-title":"Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase","volume":"162","author":"Winters","year":"2019","journal-title":"Eur J Med Chem"},{"key":"2026031614542029600_bib22","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"key":"2026031614542029600_bib23","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2026031614542029600_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1158\/1535-7163.MCT-20-0807","article-title":"Activity of combined androgen receptor antagonism and cell cycle inhibition in androgen receptor positive triple negative breast cancer","volume":"20","author":"Christenson","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"2026031614542029600_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2026031614542029600_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1089\/cmb.2017.0096","article-title":"cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing","volume":"24","author":"Kechin","year":"2017","journal-title":"J Comput Biol"},{"key":"2026031614542029600_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-sequencing aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2026031614542029600_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"2026031614542029600_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2026031614542029600_bib30","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencinguencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026031614542029600_bib31","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"2026031614542029600_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40170-023-00307-1","article-title":"Dual inhibition of IDO1\/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer","volume":"11","author":"Wu","year":"2023","journal-title":"Cancer Metab"},{"key":"2026031614542029600_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3324\/haematol.2020.246603","article-title":"Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity","volume":"106","author":"D\u2019Alessandro","year":"2021","journal-title":"Haematologica"},{"key":"2026031614542029600_bib34","doi-asserted-by":"crossref","first-page":"e146175","DOI":"10.1172\/jci.insight.146175","article-title":"Blood donor exposome and impact of common drugs on red blood cell metabolism","volume":"6","author":"Nemkov","year":"2021","journal-title":"JCI Insight"},{"key":"2026031614542029600_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/rcm.7834","article-title":"A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways","volume":"31","author":"Nemkov","year":"2017","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2026031614542029600_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4939-9236-2_2","article-title":"High-throughput metabolomics: isocratic and gradient mass spectrometry-based methods","volume":"1978","author":"Nemkov","year":"2019","journal-title":"Methods Mol Biol"},{"key":"2026031614542029600_bib37","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00726-015-2019-9","article-title":"Three-minute method for amino acid analysis by UHPLC and high-resolution quadrupole orbitrap mass spectrometry","volume":"47","author":"Nemkov","year":"2015","journal-title":"Amino Acids"},{"key":"2026031614542029600_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1541-7786.MCR-18-0246","article-title":"Reversal of triple-negative breast cancer EMT by miR-200c decreases tryptophan catabolism and a program of immunosuppression","volume":"17","author":"Rogers","year":"2019","journal-title":"Mol Cancer Res"},{"key":"2026031614542029600_bib39","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4161\/onci.21716","article-title":"IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: a novel IDO effector pathway targeted by D-1-methyl-tryptophan","volume":"1","author":"Metz","year":"2012","journal-title":"Oncoimmunology"},{"key":"2026031614542029600_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/bcr3037","article-title":"Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity","volume":"13","author":"Drasin","year":"2011","journal-title":"Breast Cancer Res"},{"key":"2026031614542029600_bib41","doi-asserted-by":"crossref","first-page":"e108647","DOI":"10.15252\/embj.2021108647","article-title":"Dynamic EMT: a multi-tool for tumor progression","volume":"40","author":"Brabletz","year":"2021","journal-title":"EMBO J"},{"key":"2026031614542029600_bib42","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.devcel.2021.11.006","article-title":"Distinct contributions of partial and full EMT to breast cancer malignancy","volume":"56","author":"L\u00fc\u00f6nd","year":"2021","journal-title":"Dev Cell"},{"key":"2026031614542029600_bib43","doi-asserted-by":"crossref","first-page":"18643","DOI":"10.1074\/jbc.M113.467787","article-title":"Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development","volume":"288","author":"Vannier","year":"2013","journal-title":"J Biol Chem"},{"key":"2026031614542029600_bib44","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1038\/onc.2010.102","article-title":"ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI\/SNF chromatin-remodeling protein BRG1","volume":"29","author":"S\u00e1nchez-Till\u00f3","year":"2010","journal-title":"Oncogene"},{"key":"2026031614542029600_bib45","doi-asserted-by":"crossref","first-page":"215601","DOI":"10.1016\/j.canlet.2022.215601","article-title":"ZEB1-regulated lnc-Nr2f1 promotes the migration and invasion of lung adenocarcinoma cells","volume":"533","author":"Kim","year":"2022","journal-title":"Cancer Lett"},{"key":"2026031614542029600_bib46","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/emmm.201302827","article-title":"The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance","volume":"5","author":"Siebzehnrubl","year":"2013","journal-title":"EMBO Mol Med"},{"key":"2026031614542029600_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopha.2018.11.112","article-title":"The roles of ZEB1 in tumorigenic progression and epigenetic modifications","volume":"110","author":"Zhang","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2026031614542029600_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"ENCODE Project Consortium","year":"2012","journal-title":"Nature"},{"key":"2026031614542029600_bib49","doi-asserted-by":"crossref","first-page":"e17911","DOI":"10.1371\/journal.pone.0017911","article-title":"GOBO: gene expression-based outcome for breast cancer online","volume":"6","author":"Ringn\u00e9r","year":"2011","journal-title":"PLoS One"},{"key":"2026031614542029600_bib50","doi-asserted-by":"crossref","first-page":"145736","DOI":"10.1016\/j.gene.2021.145736","article-title":"TDO2 knockdown inhibits colorectal cancer progression via TDO2-KYNU-AhR pathway","volume":"792","author":"Zhao","year":"2021","journal-title":"Gene"},{"key":"2026031614542029600_bib51","doi-asserted-by":"crossref","first-page":"18771","DOI":"10.1021\/jacs.9b08871","article-title":"Structural basis of inhibitor selectivity in human indoleamine 2,3-dioxygenase 1 and tryptophan dioxygenase","volume":"141","author":"Pham","year":"2019","journal-title":"J Am Chem Soc"},{"key":"2026031614542029600_bib52","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/0284186X.2021.1881161","article-title":"PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS","volume":"60","author":"Abdulla","year":"2021","journal-title":"Acta Oncol"},{"key":"2026031614542029600_bib53","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8+ T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026031614542029600_bib54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0900408","article-title":"Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression","volume":"183","author":"Liu","year":"2009","journal-title":"J Immunol"},{"key":"2026031614542029600_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00281-018-0702-0","article-title":"Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond","volume":"41","author":"Muller","year":"2019","journal-title":"Semin Immunopathol"},{"key":"2026031614542029600_bib56","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol"},{"key":"2026031614542029600_bib57","doi-asserted-by":"crossref","first-page":"zcab014","DOI":"10.1093\/narcan\/zcab014","article-title":"Inhibition of tryptophan 2,3-dioxygenase impairs DNA damage tolerance and repair in glioma cells","volume":"3","author":"Reed","year":"2021","journal-title":"NAR Cancer"},{"key":"2026031614542029600_bib58","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/embor.2008.74","article-title":"A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells","volume":"9","author":"Burk","year":"2008","journal-title":"EMBO Rep"},{"key":"2026031614542029600_bib59","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1038\/s41467-018-07130-z","article-title":"Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion","volume":"9","author":"Title","year":"2018","journal-title":"Nat Commun"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0272\/3499446\/crc-24-0272.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/10\/2699\/3507873\/crc-24-0272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/10\/2699\/3507873\/crc-24-0272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:54:32Z","timestamp":1773687272000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/10\/2699\/749104\/Blocking-Tryptophan-Catabolism-Reduces-Triple"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0272","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.28728161","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762190","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240969","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728185","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240957","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240921","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240945","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240933","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248918","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762178","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762166","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240909","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728173","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248930","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240993","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248966","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240981","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248942","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248954","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728170","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240954","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240942","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728158","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762187","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728146","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762232","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762175","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728134","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762199","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240918","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728182","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762163","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728194","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762229","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762217","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762205","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240930","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248957","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248969","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248933","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248945","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27241002","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248921","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240903","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240927","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240987","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728179","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240999","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728167","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728155","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728191","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728143","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762172","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240939","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762196","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762184","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248960","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248972","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762226","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762169","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762214","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762202","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248948","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27241005","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240963","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248924","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248936","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240936","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240924","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762181","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240948","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728188","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27241008","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240912","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248939","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240900","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728176","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728164","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762193","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728152","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728140","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248951","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248963","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728149","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728137","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762223","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240972","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248915","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248927","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240996","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27240984","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27248975","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7496154","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}